Bracco files patent complaint against Jubilant for rubidium-82 generators

Anicka Slachta | | Radiology Business | Policy & Regulations

Imaging giant Bracco Diagnostics has filed a complaint with the U.S. International Trade Commission against Jubilant DraxImage, a Canadian radiopharmaceutical firm, requesting the ITC halt imports of Jubilant’s Ruby-Fill rubidium-82 generators and related components.

Bracco’s patent complaint alleges violations of the Tariff Act of 1930, according to the paperwork, and includes a request for a cease and desist order that would bar any distribution of Ruby-Fill systems and generators that have already been imported to the U.S. 

The company also asked the ITC to impose a bond on the allegedly infringed-upon products, which would prohibit sales during the complaint’s 60-day review period.

In addition to Jubilant DraxImage, which is based in Canada, Bracco Diagnostics is lodging complaints against the company’s Indian and Singaporean affiliates—Jubilant Life Sciences and Jubilant Pharma, respectively. 

The public has been welcomed to file comments pertaining to the complaint.

""
Anicka Slachta

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Related Content

Physician Medicare pay fix in jeopardy following criticism from Donald Trump, Elon Musk
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’
Radiologists push governor to veto bill that would produce ‘staggering’ increase in liability premiums
Radiology experts say state Medicaid rates must increase to improve imaging access
Policy reforms in Washington that will impact nuclear imaging
U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.